Canadian firm's implant controls glucose in diabetic pigs

07/12/2010 | Reuters

Diabetic pigs treated with Sernova's Cell Pouch System showed long-term normal glucose levels without experiencing adverse events, according to preclinical trials. The implantable device uses insulin-producing tissues, or islets, derived from the pancreas of the animals to enable the therapeutic cells to thrive and function in a natural environment.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA